收费全文 | 3542篇 |
免费 | 206篇 |
国内免费 | 24篇 |
耳鼻咽喉 | 37篇 |
儿科学 | 77篇 |
妇产科学 | 170篇 |
基础医学 | 451篇 |
口腔科学 | 116篇 |
临床医学 | 270篇 |
内科学 | 821篇 |
皮肤病学 | 52篇 |
神经病学 | 165篇 |
特种医学 | 99篇 |
外国民族医学 | 1篇 |
外科学 | 578篇 |
综合类 | 74篇 |
预防医学 | 273篇 |
眼科学 | 185篇 |
药学 | 242篇 |
中国医学 | 11篇 |
肿瘤学 | 150篇 |
2023年 | 25篇 |
2022年 | 91篇 |
2021年 | 160篇 |
2020年 | 67篇 |
2019年 | 106篇 |
2018年 | 118篇 |
2017年 | 99篇 |
2016年 | 93篇 |
2015年 | 95篇 |
2014年 | 160篇 |
2013年 | 181篇 |
2012年 | 223篇 |
2011年 | 252篇 |
2010年 | 140篇 |
2009年 | 132篇 |
2008年 | 181篇 |
2007年 | 172篇 |
2006年 | 157篇 |
2005年 | 166篇 |
2004年 | 138篇 |
2003年 | 116篇 |
2002年 | 97篇 |
2001年 | 65篇 |
2000年 | 68篇 |
1999年 | 55篇 |
1998年 | 21篇 |
1997年 | 16篇 |
1996年 | 21篇 |
1995年 | 15篇 |
1994年 | 17篇 |
1993年 | 14篇 |
1992年 | 54篇 |
1991年 | 50篇 |
1990年 | 47篇 |
1989年 | 49篇 |
1988年 | 28篇 |
1987年 | 29篇 |
1986年 | 33篇 |
1985年 | 30篇 |
1984年 | 24篇 |
1983年 | 14篇 |
1982年 | 12篇 |
1981年 | 9篇 |
1979年 | 20篇 |
1978年 | 11篇 |
1976年 | 10篇 |
1974年 | 10篇 |
1973年 | 11篇 |
1971年 | 10篇 |
1970年 | 9篇 |
Background
Type 2 diabetes is a chronic condition that requires pharmacotherapy interventions. Metformin and gliclazide are widely used drugs in monotherapy. However, their complementary action made utilization of the combination of these drugs an appealing approach.Aims
The study compared major therapeutic potentials of combined metformin/gliclazide treatment over metformin monotherapy based on the following parameters: oxidative stress, lipid profile, and hepatorenal functions.Subjects and methods
This is a comparative study was conducted from March 2015 to March 2016. The study screened 80 type 2 diabetic patients, of which 40 patients underwent combined metformin?+?gliclazide therapy (500?mg BD?+?80?mg OD, respectively). The other 40 were matched for age and duration of diabetes mellitus with the previous group and received metformin monotherapy (500?mg BD). The levels of fasting blood glucose (FBG), total glycated hemoglobin (HbA1c), lipid peroxidation, total antioxidant capacity, serum creatinine, aspartate and alanine transaminases, total cholesterol, triglycerides, high-density lipoproteins, and low-density lipoproteins were measured according to the standard methods.Results
Oxidative stress, lipid profile, and hepatorenal functions were comparable in patients of both groups. However, patients on metformin treatment showed significantly lower levels of FBG [7.61 (6.70–8.89) mmol/L vs. 9.00 (7.30–10.68) mmol/L; P?=?.022] and HBA1c [7.00 (6.40–7.65)% vs. 8.20 (7.20–9.75)%; P?<?.001] compared to those on combined therapy.Conclusion
Oxidative stress, lipids profile, and hepatorenal functions were not different in patients who were on combined metformin/gliclazide therapy and compared to those metformin alone. In contrast, glycemic control was poor in the diabetic patients undergoing combined therapy. 相似文献Objective
To assess community pharmacists’ knowledge, behaviors and experiences relating to Adverse Drug Reaction (ADR) reporting in Saudi Arabia.Methods
A cross-sectional study was conducted using a validated self-administered questionnaire. A convenience sample of 147 community pharmacists working in community pharmacies in Riyadh, Saudi Arabia.Results
The questionnaire was distributed to 147 pharmacists, of whom 104 responded to the survey, a 70.7% response rate. The mean age of participants was 29 years. The majority (n = 101, 98.1%) had graduated with a bachelorette degree and worked in chain pharmacies (n = 68, 66.7%). Only 23 (22.1%) said they were familiar with the ADR reporting process, and only 21 (20.2%) knew that pharmacists can submit ADR reports online. The majority of the participants (n = 90, 86.5%) had never reported ADRs. Reasons for not reporting ADRs most importantly included lack of awareness about the method of reporting (n = 22, 45.9%), misconception that reporting ADRs is the duty of physician and hospital pharmacist (n = 8, 16.6%) and ADRs in community pharmacies are simple and should not be reported (n = 8, 16.6%). The most common approach perceived by community pharmacists for managing patients suffering from ADRs was to refer him/her to a physician (n = 80, 76.9%).Conclusion
The majority of community pharmacists in Riyadh have poor knowledge of the ADR reporting process. Pharmacovigilance authorities should take necessary steps to urgently design interventional programs in order to increase the knowledge and awareness of pharmacists regarding the ADR reporting process. 相似文献Idiopathic junctional ectopic tachycardia (JET) is typically refractory to antiarrhythmic agents. Catheter ablation for JET is feasible but is associated with high risk of unintended atrioventricular (AV) block. There is limited data on the appropriate procedural technique and clinical outcomes with catheter ablation for idiopathic JET in adults.
MethodsThis is a multicenter, retrospective study of all adult patients (age?≥?18 years) who underwent catheter ablation for idiopathic JET. Patient, procedural characteristics, and long-term outcomes were evaluated.
ResultsFifteen patients [radiofrequency ablation (RF)?=?14 and cryoablation?=?1) were treated with catheter ablation. The median age was 58 years with 67% males. All patients underwent mapping of the right atrium and the aortic cusps prior to energy delivery. The location of earliest activation in relation to the atrioventricular (AV) node was postero-superior in 73% (11/15), posterior in 13% (2/15), and superior in 13% (2/15) respectively. Acute success was 100%. Arrhythmia recurrence occurred in 53% (8/15) all of whom underwent a repeat ablation. High-grade AV block requiring permanent pacemaker occurred in 20% (3/15). At 12-month follow-up in the redo-ablation group, 37.5% (3/8) had recurrence of the arrhythmia two of which underwent a third ablation procedure.
ConclusionCatheter ablation of idiopathic JET in adults is associated with a high rate of recurrence requiring multiple procedures and high risk of AV block requiring a permanent pacemaker. Mapping and ablation of the non-coronary cusp can be considered as the arrhythmia was controlled in 3 patients with no inadvertent AV block.
相似文献